Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer

European Journal of Surgical Oncology

Volumn 37, Issue 1, 2011, Pages 4-9

  Deraco, M ^a   Baratti, D ^a   Laterza, B ^a   Balestra, M R ^a   Mingrone, E ^b   MacRì, Antonio ^c   Virzi S ^d   Puccio, F ^d   Ravenda, P S ^e   Kusamura, S ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d Department of General Surgery ^*  (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cytoreductive surgery; Epithelial ovarian cancer; Hyperthermic intraperitoneal chemotherapy; Peritoneal carcinomatosis; Peritonectomy

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; GEMCITABINE; MITOMYCIN C; MITOXANTRONE; OXALIPLATIN; PACLITAXEL; PLATINUM COMPLEX;

APPENDIX CANCER; AREA UNDER THE CURVE; CANCER CHEMOTHERAPY; CARCINOMATOUS PERITONITIS; CLINICAL TRIAL; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; DRUG CYTOTOXICITY; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; LIVER RESECTION; MEDICAL LITERATURE; MINIMAL RESIDUAL DISEASE; OVARY ADENOCARCINOMA; OVARY CACINOMA; OVARY CANCER; OVARY CARCINOMA; PERITONEUM MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVIEW; SPLENECTOMY; SURGICAL APPROACH; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; STANDARD OF CARE;

EID: 78650284840     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.11.004     Document Type: Review

References (55)

1. R. Yancik EOC: age contrasts in incidence, histology, disease stage at diagnosis, and mortality Cancer 71 2 Suppl. 1993 517 523
2. R. Hogg, and M. Friedlander Biology of epithelial EOC: implications for screening women at high genetic risk J Clin Oncol 22 2004 1315 1327
3. W.P. McGuire, W.J. Hoskin, and M.F. Brady Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and IV EOC N Engl J Med 334 1996 1 6
4. R.F. Ozols, and R.C. Young EOC Curr Probl Cancer 11 1988 57 122
5. R.E. Bristow, R.S. Tomacruz, D.K. Armstrong, E.L. Trimble, and F.J. Montz Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 20 2002 1248 1259
6. W.E. Winter 3rd, G.L. Maxwell, C. Tian Gynecologic Oncology Group Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial EOC: a Gynecologic Oncology Group study J Clin Oncol 26 2008 83 89
7. S.M. Eisenkop, and N.M. Spirtos What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial EOC? Gynecol Oncol 82 2001 489 497
8. S.M. Eisenkop, and N.M. Spirtos Procedures required to accomplish complete cytoreduction of EOC: is there a correlation with "biological aggressiveness" and survival? Gynecol Oncol 82 2001 435 441
9. D.S. Chi, E.L. Eisenhauer, and O. Zivanovic Improved progression-free and overall survival in advanced EOC as a result of a change in surgical paradigm Gynecol Oncol 114 2009 26 31
10. J. Pfisterer, B. Weber, A. Reuss AGO-OVAR GINECO Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced EOC: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO J Natl Cancer Inst 98 2006 1036 1045
11. S.C. Crawford, P.A. Vasey, J. Paul, A. Hay, J.A. Davis, and S.B. Kaye Does aggressive surgery only benefit patients with less advanced EOC? Results from an international comparison within the SCOTROC-1 Trial J Clin Oncol 23 2005 8802 8811 [Erratum in: J Clin Oncol 2006;24:1224]
12. S.F. Adams, D.A. Levine, and M.G. Cadungog Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous EOC Cancer 115 2009 2891 2902
13. P.H. Sugarbaker Peritonectomy procedures Ann Surg 221 1995 29 42
14. M. Deraco, D. Baratti, S. Kusamura, B. Laterza, and M.R. Balestra Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies J Surg Oncol 100 2009 321 328
15. D.K. Armstrong, B. Bundy, and L. Wenzel Intraperitoneal cisplatin and paclitaxel in EOC N Engl J Med 354 2006 34 43
16. K. Jaaback, and N. Johnson Intraperitoneal chemotherapy for the initial management of primary epithelial EOC Cochrane Database Syst Rev 1 2006 CD005340
17. K. Rowan Intraperitoneal therapy for EOC: why has it not become standard? J Natl Cancer Inst 101 2009 775 777
18. T.D. Yan, D. Black, R. Savady, and P.H. Sugarbaker A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei Ann Surg Oncol 14 2007 484 492 (Pubitemid 46175292)
19. T.D. Yan, D. Black, R. Savady, and P.H. Sugarbaker Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma J Clin Oncol 24 2006 4011 4019
20. T.D. Yan, M. Deraco, and D. Baratti Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience J Clin Oncol 27 2009 6237 6242
21. T.C. Chua, G. Robertson, and W. Liauw Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in EOC peritoneal carcinomatosis: systematic review of current results J Cancer Res Clin Oncol 135 2009 1637 1645
22. Vergote CG, Trope F, Amant GB, et al. EORTC-GCG/NCIC-CTG randomized trial comparing primary debulking surgery with neoadjuvant chemotherapy in stage IIIC-IV ovarian, fallopian tube and peritoneal cancer. In: Plenary presentation at the 12th Biennial meeting. International Gynecologic Cancer Society IGCS, Bangkok, Thailand; October 25-28, 2008 [abstract].
23. S. Kang, and B.H. Nam Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies Ann Surg Oncol 16 2009 2315 2320
24. J.H. Kim, J.M. Lee, and K.S. Ryu Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer J Surg Oncol 101 2010 149 155
25. C. Pomel, G. Ferron, and G. Lorimier Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study Eur J Surg Oncol 36 2010 589 593
26. K. Galaal, R. Naik, R.E. Bristow, A. Patel, A. Bryant, and H.O. Dickinson Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer Cochrane Database Syst Rev 16 2010 CD007822 [Review]
27. Study comparing tumor debulking surgery versus chemotherapy alone in Recurrent Platinum-Sensitive Ovarian Cancer AGO-OVAR OP.4 DESKTOP III, NCT01166737 http://www.cancer.gov/search/ResultsClinicalTrials.aspx? protocolsearchid=8354416
28. P. Harter, M. Hahmann, and H.J. Lueck Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis Ann Surg Oncol 16 2009 1324 1330
29. J.V. Hettinga, W. Lemstra, and C. Meijer Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells Br J Cancer 75 1997 1735 1743
30. M. Deraco, F. Raspagliesi, and S. Kusamura Management of peritoneal surface component of ovarian cancer Surg Oncol Clin N Am 12 2003 561 583 [review]
31. A. Fagotti, I. Paris, and F. Grimolizzi Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study Gynecol Oncol 113 2009 335 340
32. C.W. Helm, R.E. Bristow, S. Kusamura, D. Baratti, and M. Deraco Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer J Surg Oncol 98 2008 283 290
33. G.D. Aletti, H.J. Long, K.C. Podratz, and W.A. Cliby Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer? Gynecol Oncol 104 2007 212 216
34. E. Chéreau, M. Ballester, F. Selle, A. Cortez, E. Daraï, and R. Rouzier Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer Am J Obstet Gynecol 202 2010 178.e1 178.e10
35. D.L. Bartlett, J.F. Buell, and S.K. Libutti A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis Cancer 83 1998 1251 1261
36. C.R. Rossi, M. Foletto, and S. Mocellin Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study Cancer 15 94 2002 492 499
37. L.E. Harrison, M. Bryan, L. Pliner, and T. Saunders Phase I trial of pegylated liposomal doxorubicin with hyperthermic intraperitoneal chemotherapy in patients undergoing cytoreduction for advanced intra-abdominal malignancy Ann Surg Oncol 15 2008 1407 1413
38. M. Markman, M.F. Brady, N.M. Spirtos, P. Hanjani, and S.C. Rubin Phase II trial of intraperitoneal Paclitaxel in carcinoma of the ovary, tube and peritoneum: a Gynecologic Oncology Group Study J Clin Oncol 16 1998 2620 2624
39. M.O. Nicoletto, R. Padrini, and F. Galeotti Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in EOC Cancer Chemother Pharmacol 45 2000 457 462
40. S.S. Lentz, B.E. Miller, G.L. Kucera, and E.A. Levine Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinoma Gynecol Oncol 106 2007 207 210
41. R.J. Morgan Jr., T.W. Synold, and B. Xi Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity Clin Cancer Res 13 2007 1232 1237
42. E. de Bree, H. Rosing, and D. Filis Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study Ann Surg Oncol 15 2008 1183 1192
43. R.M. Smeenk, V.J. Verwaal, and F.A. Zoetmulder Learning curve of combined modality treatment in peritoneal surface disease Br J Surg 94 2007 1408 1414
44. OVHIPEC trial; ClinicalTrials.gov identifier: NCT00426257 http://clinicaltrials.gov/ct2/show/NCT00426257
45. T.C. Chua, W. Liauw, and G. Robertson Towards randomized trials of cytoreductive surgery using peritonectomy and hyperthermic intraperitoneal chemotherapy for ovarian cancer peritoneal carcinomatosis Gynecol Oncol 114 2009 137 139
46. J.M. Classe, M. Muller, and J.S. Frenel La chimiothérapie intrapéritonéale dans les cancers de l'ovaire Intra peritoneal chemotherapy in the treatment of advanced ovarian cancer Mémoires de l'Académie Nationale de Chirurgie 8 2009 86 90
47. J. Bereder, O. Glehen, and J. Habre Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from ovarian cancer: a multiinstitutional study of 246 patients J Clin Oncol 27 15s 2009 5542 [abstract]
48. M.J. Pavlov, P.A. Kovacevic, and M.S. Ceranic Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer - 12-year single center experience Eur J Surg Oncol 35 2009 1186 1191
49. E. Guardiola, D. Delroeux, and B. Heyd Intra operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer World J Surg Oncol 9 2009 14
50. A. Di Giorgio, E. Naticchioni, and D. Biacchi Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diVuse peritoneal carcinomatosis from ovarian cancer Cancer 113 2008 315 325
51. J.H. Bae, J.M. Lee, and K.S. Ryu Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery Gynecol Oncol 106 2007 193 200
52. E. Cotte, O. Glehen, and F. Mohamed Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients World J Surg 31 2007 1813 1820
53. S. Rufian, F.C. Munoz-Casares, and J. Briceno Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer J Surg Oncol 94 2006 316 324
54. F. Raspagliesi, S. Kusamura, and J.C. Campos Torres Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: the experience of National Cancer Institute of Milan Eur J Surg Oncol 32 2006 671 675
55. K.S. Ryu, J.H. Kim, and H.S. Ko Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer Gynecol Oncol 94 2004 325 332